Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody designed for dual targeting of B-cell activating factor (BAFF) and interleukin-17A (IL-17A), exhibiting high affinity with dissociation constants (Kd) of 60 pM and 14 pM, respectively. This antibody is specifically engineered for the study of autoimmune diseases, providing a valuable tool for investigating the pathophysiological roles of BAFF and IL-17A in immune modulation and inflammation.
Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody designed for dual targeting of B-cell activating factor (BAFF) and interleukin-17A (IL-17A), exhibiting high affinity with dissociation constants (Kd) of 60 pM and 14 pM, respectively. This antibody is specifically engineered for the study of autoimmune diseases, providing a valuable tool for investigating the pathophysiological roles of BAFF and IL-17A in immune modulation and inflammation.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
